FEI 3003289270 of Neuland Laboratories Limited | GDUFA | Fees | Self Identification | PharmaCompass.com

Please Wait

Applying Filters...

Neuland Laboratories

Neuland Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

9 Corporate Content #SupplierSpotlight, 3 Data Compilation #PharmaFlow, 65 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

118 All APIs, 56 USDMF, 7 CEP/COS, 4 JDMF, 50 EU WC, 48 KDMF, 41 NDC API, 70 Listed APIs

KEY PRODUCTS

Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Difelikefalin Acetate, Empagliflozin, Ensifentrine, Fezolinetant, Mirabegron, Tapinarof, Tirzepatide, Vilanterol Trifenatate, Vonoprazan Fumarate

SERVICES

Analytical, API Manufacturing, API & Drug Product Development

Analytical
- 1 Analytical Method Development
API Manufacturing
API & Drug Product Development
- 7 API Development

INSPECTIONS & REGISTRATIONS

12 FDA, 3 EDQM, 3 GDUFA

Xls

Filters

Filters

FILTER :

filter Registrant Name Reset all filters

1 All

01 1Neuland Laboratories Limited

filter Facility Name Reset all filters

filter API Manufacture Reset all filters

List of Suppliers

Supplier Virtual Booth

price-trend

01

GDUFA fees paid

USA

CPhI WW Frankfurt

Neuland Laboratories- A dedicated 100% API provider.

Paid in : 2025

Neuland Laboratories

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Neuland Laboratories Limited

Business Address : Unit-I, Sy. No: 347, 473, 47...

FEI Number : 3003289270

Country : India

Paid in : 2025

Product
Web Link

Stock Recap
#PipelineProspector

Contact us
to update this info